Prometei Pain Rehabilitation Center

Lumosa is pleased to share the results of clinical trials for Esthesia, which is the brand name of Lumosa’s LT1001 long-acting analgesic injection in Ukraine. The study looked at LT1001 as part of a multimodal approach to manage pain after surgery for patients with injuries from mines and explosives. The study involved 15 patients who received a single 150 mg/2 ml injection of LT1001 intramuscularly 12-24 hours before reconstructive surgery. The study found that pain levels measured by Visual Analogue Scale (VAS) decreased 6 hours after surgery compared to 6-8 hours after giving the drug. Pain relief remained steady for four days after surgery, and researchers found no strong link between Injury Severity Score (ISS) and VAS. The study showed that LT1001 is well tolerated and is effective in postoperative pain management for those having reconstructive procedures due to injuries from mines and explosives.   These findings show how LT1001 could help tackle the tricky issues of easing pain in severe trauma cases. Since injuries from mines and explosives often need complex surgery, and well managed pain control is key for patients to heal and rehabilitate. We believe that LT1001 could play a significant role in improving postoperative care for trauma patients.   As we share these results, we are acutely aware of the ongoing conflict in Ukraine where the study took place. Our hearts go out to all those affected by the war, While our mission is to advance medical science, we hope for a world where treatments for war injuries are no longer necessary.   Link to article: https://lnkd.in/g3sRX3An

Our great friend Max J. Ortiz Catalán Ortiz Catalan is in our center today. We work to overcome chronic pain. #painrelief #painresearch #chronicpain #paintreatment

👋, Good day! The long-suffering article is finally published. 🔺An article that reflects all the pain of our country. The pain of war, the pain of the lack of medicine in cities where bombs were arriving every minute, behind every patient there is a story of indomitability and pain. 📍The article was submitted to 17 magazines and almost all advised to remove the words "WAR" and "russia WAR". They advised to write "conflict" and not only that, they advised to give up and not to print. 📌The article about 60 days of war and pain - after all, it goes to the 2nd year of the war.💪 Glory to UKRAINE!💙💛 Dmytriiev, D., Garland, E.L. Chronic pain during 60 days of war: the impact of the Russian war on Ukrainian patients. J Public Health (Berl.) (2024). https://lnkd.in/eJxHyQnS #painrelief #pain #painmedicine #dogood

https://lnkd.in/erJ83N4V